Junttila et al. [4] demonstrated in the TRAMP mouse model that ERK activation is linked to prostatic epithelial proliferation and initiation of prostate cancer development, while ERK inactivation is correlated with the emergence of a poorly differentiated metastatic and androgen-independent phenotype. The gene discussed is MAPK1; the disease is prostate cancer.